These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22168450)

  • 1. Hereditary protein C deficiency and thrombosis risk: genotype and phenotype relation in a large Italian family.
    Cafolla A; D'Andrea G; Baldacci E; Margaglione M; Mazzucconi MG; Foà R
    Eur J Haematol; 2012 Apr; 88(4):336-9. PubMed ID: 22168450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of prothrombin 20210A allele and factor V Leiden mutation to thrombosis risk in thrombophilic families with other hemostatic deficiencies.
    Tirado I; Mateo J; Soria JM; Oliver A; Borrell M; Coll I; Vallvé C; Souto JC; Martínez-Sánchez E; Fontcuberta J
    Haematologica; 2001 Nov; 86(11):1200-8. PubMed ID: 11694407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hereditary protein C deficiency caused by the Ala267Thr mutation in the protein C gene is associated with symptomatic and asymptomatic venous thrombosis.
    Tjeldhorn L; Sandset PM; Haugbro K; Skretting G
    Thromb Res; 2010 Mar; 125(3):230-4. PubMed ID: 19535131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of F139V mutation on thrombotic events in compound heterozygous and homozygous protein C deficiency.
    Yang LH; Zheng FX; Chen Y; Jin YH; Zhang Z; Xie HX; Yang XL; Wang MS; Chen BC
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):824-30. PubMed ID: 24911457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different impact of two mutations of a novel compound heterozygous protein C deficiency with late onset thrombosis.
    Yang LH; Wang MS; Zheng FX; Li J; Chen Y; Jin YH; Xie HX; Yang XL; Chen BC
    Genet Mol Res; 2014 Apr; 13(2):2969-77. PubMed ID: 24782131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two common genetic thrombotic risk factors: factor V Leiden and prothrombin G20210A in adult Turkish patients with thrombosis.
    Gurgey A; Haznedaroglu IC; Egesel T; Buyukasik Y; Ozcebe OI; Sayinalp N; Dundar SV; Bayraktar Y
    Am J Hematol; 2001 Jun; 67(2):107-11. PubMed ID: 11343382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High risk of thrombosis recurrence in patients with homozygous and compound heterozygous factor V R506Q (Factor V Leiden) and prothrombin G20210A.
    Federici EH; Al-Mondhiry H
    Thromb Res; 2019 Oct; 182():75-78. PubMed ID: 31472339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds.
    Simioni P; Scudeller A; Radossi P; Gavasso S; Girolami B; Tormene D; Girolami A
    Thromb Haemost; 1996 Mar; 75(3):422-6. PubMed ID: 8701401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial thrombotic risk based on the genetic background of Protein C Deficiency in a Portuguese Study.
    Fidalgo T; Martinho P; Salvado R; Manco L; Oliveira AC; Pinto CS; Gonçalves E; Marques D; Sevivas T; Martins N; Ribeiro ML
    Eur J Haematol; 2015 Oct; 95(4):294-307. PubMed ID: 25533856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor V Leiden (Arg506Gln), a confounding genetic risk factor but not mandatory for the occurrence of venous thromboembolism in homozygotes and obligate heterozygotes for cystathionine beta-synthase deficiency.
    Yap S; O'Donnell KA; O'Neill C; Mayne PD; Thornton P; Naughten E
    Thromb Haemost; 1999 Apr; 81(4):502-5. PubMed ID: 10235428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and analytical relevance of the combination of prothrombin 20210A/A and factor V Leiden: results from a large family.
    Corral J; Zuazu-Jausoro I; Rivera J; González-Conejero R; Ferrer F; Vicente V
    Br J Haematol; 1999 May; 105(2):560-3. PubMed ID: 10233438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.
    van Boven HH; Reitsma PH; Rosendaal FR; Bayston TA; Chowdhury V; Bauer KA; Scharrer I; Conard J; Lane DA
    Thromb Haemost; 1996 Mar; 75(3):417-21. PubMed ID: 8701400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the factor V Leiden mutation in septic peritonitis assessed in factor V Leiden transgenic mice.
    Brüggemann LW; Schoenmakers SH; Groot AP; Reitsma PH; Spek CA
    Crit Care Med; 2006 Aug; 34(8):2201-6. PubMed ID: 16775574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of a functional prothrombin time-based assay for identification of factor V Leiden carriers in a group of Italian patients with venous thrombosis.
    Gessoni G; Valverde S
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):603-10. PubMed ID: 17890946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of a hereditary protein C deficient consanguineous pedigree caused by Phe139Val homozygous mutation].
    Yang LH; Zhu LQ; Wang YY; Xie HX; Xie YS; Jin YH; Wang MS; Chen BC; Yang XL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):767-70. PubMed ID: 24103874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The G20210A prothrombin polymorphism is not associated with increased thromboembolic risk in a large protein C deficient kindred.
    Bovill EG; Hasstedt SJ; Callas PW; Valliere JE; Scott BT; Bauer KA; Long GL
    Thromb Haemost; 2000 Mar; 83(3):366-70. PubMed ID: 10744139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical manifestations in thrombotic children with factor V Leiden mutation.
    Gurgey A
    Pediatr Hematol Oncol; 1999; 16(3):233-7. PubMed ID: 10326221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein C and protein S assessment in hospital laboratories: which strategy and what role for DNA sequencing?
    Labrouche S; Reboul MP; Guérin V; Vergnes C; Freyburger G
    Blood Coagul Fibrinolysis; 2003 Sep; 14(6):531-8. PubMed ID: 12960605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene mutations in 21 unrelated cases of phenotypic heterozygous protein C deficiency and thrombosis. Protein C Study Group.
    Ireland H; Thompson E; Lane DA
    Thromb Haemost; 1996 Dec; 76(6):867-73. PubMed ID: 8972002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.